Cas:14435-88-2 2,6-di(4-methylphenyl)pyridine manufacturer & supplier

Chemical Name:2,6-di(4-methylphenyl)pyridine

CAS.NO:14435-88-2

Synonyms:2,6-di(4-methylphenyl)pyridine;2,6-Bis(4-methylphenyl)pyridine;2,6-Bis(p-tolyl)pyridine;2,6-di-(p-tolyl)-pyridine;2,4:3,5-DI-O-BENZYLIDENE-L-IDARIC ACID;2,6-Bis(4-methylphenyl)pyridin;Pyridine, 2,6-bis(4-methylphenyl)-;Pyridine,2,6-di-p-tolyl;2,6-bis-(4-methylphenyl)pyridine;2,6-di(4-tolyl)pyridine

Molecular Formula:C₁₉H₁₇N

Molecular Weight:259.345

HS Code:2933399090

Physical and Chemical Properties:

Melting point:163-165ºC

Boiling point:402.5±14.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.592

PSA:12.89000

Exact Mass:259.136108

LogP:5.74

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2,6-di(4-methylphenyl)pyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,6-di(4-tolyl)pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,6-Bis(4-methylphenyl)pyridin Use and application,2,6-bis-(4-methylphenyl)pyridine technical grade,usp/ep/jp grade.

Related News: The latest outbreak comes as China grapples with an African swine fever epidemic that has infected tens of thousands of pigs. It could stoke more worries among its people about the country��s food supply. 2,6-di(4-methylphenyl)pyridine manufacturer This is very visible in herbal medicines in which the API is frequently a combination of several mixtures and/or substances which when used together cause pharmacological activity on the body. 2,6-di(4-methylphenyl)pyridine supplier The latest outbreak comes as China grapples with an African swine fever epidemic that has infected tens of thousands of pigs. It could stoke more worries among its people about the country��s food supply. 2,6-di(4-methylphenyl)pyridine vendor Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching. 2,6-di(4-methylphenyl)pyridine factory Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the global pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules.